Skip to main content

Table 2 Median and distribution of infliximab serum trough levels

From: Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

 

Prior to

infusion

1 hour after

infusion

50% of the

infusioncycle

75% of the

infusioncycle

100% of the

infusioncycle

Median infliximab levels

Median infliximab levels (p25-p75)

0.6 (0.0 - 3.1)

77.0 (65-89)

5.9 (1.5-13)

2.7 (0.2-5.7)

0.0 (0.0-3.1).